ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Chiral Quest will build a current Good Manufacturing Practice-compliant pilot plant and process R&D center in BioBay, part of China's Suzhou Industrial Park. To be completed in May 2009, the center will eventually house some 400 R&D and operations employees. It will be built and financed in part by BioBay. Additionally, Chiral Quest has won $13 million in financing from several China-based venture capital firms, including KPCB China and China Spring Fund. Chiral Quest CEO Joseph Marasco says the plant and financing will help his firm move beyond catalyst development and into production of chiral intermediates and pharmaceutical chemicals.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter